In this presentation, Anand A. Patel, MD, reviewed the contemporary standard-of-care treatment roadmap for AML in 2025, covering key phases like induction chemotherapy (eg, the “7+3” regimen), consolidation…
Eunice S. Wang, MD, Roswell Park Comprehensive Cancer Center, Buffalo, New York, discusses the treatment strategies for patients who develop secondary acute myeloid leukemia (AML) following hypomethylating agent…
HPV vaccination can prevent cervical cancer. Currently, there are two vaccines focused on this virus and its most dangerous types. Both are effective against HPV 16 and 18,…
The trial revealed a linear correlation between higher tumor burden and anti-PD1 and anti-programmed death ligand (PD-L1) checkpoint inhibitors, explained as the immune system responding to reactivation.
Virtually all cervical cancers are caused by the human papillomavirus (HPV). There are more than 200 HPV subtypes and at least 13 are carcinogenic. Two subtypes, HPV 16…
